| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.21 | 0.002 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.005 |